nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—Risedronate—osteoporosis	0.233	0.41	CbGbCtD
Etodolac—ALB—Estropipate—osteoporosis	0.112	0.196	CbGbCtD
Etodolac—SLC22A6—Conjugated Estrogens—osteoporosis	0.062	0.109	CbGbCtD
Etodolac—CYP2C9—Estropipate—osteoporosis	0.0601	0.106	CbGbCtD
Etodolac—ALB—Estradiol—osteoporosis	0.0463	0.0814	CbGbCtD
Etodolac—CYP2C9—Cholecalciferol—osteoporosis	0.031	0.0544	CbGbCtD
Etodolac—CYP2C9—Estradiol—osteoporosis	0.025	0.0439	CbGbCtD
Etodolac—Vertigo—Conjugated Estrogens—osteoporosis	0.000258	0.000797	CcSEcCtD
Etodolac—Hyperhidrosis—Pamidronate—osteoporosis	0.000258	0.000796	CcSEcCtD
Etodolac—Syncope—Conjugated Estrogens—osteoporosis	0.000258	0.000796	CcSEcCtD
Etodolac—Hypertension—Zoledronate—osteoporosis	0.000258	0.000796	CcSEcCtD
Etodolac—Hypersensitivity—Alendronate—osteoporosis	0.000258	0.000795	CcSEcCtD
Etodolac—Headache—Etidronic acid—osteoporosis	0.000257	0.000794	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000256	0.000789	CcSEcCtD
Etodolac—Asthenia—Estropipate—osteoporosis	0.000255	0.000786	CcSEcCtD
Etodolac—Visual impairment—Estradiol—osteoporosis	0.000255	0.000786	CcSEcCtD
Etodolac—Anorexia—Pamidronate—osteoporosis	0.000254	0.000785	CcSEcCtD
Etodolac—Arthralgia—Zoledronate—osteoporosis	0.000254	0.000785	CcSEcCtD
Etodolac—Myalgia—Zoledronate—osteoporosis	0.000254	0.000785	CcSEcCtD
Etodolac—Palpitations—Conjugated Estrogens—osteoporosis	0.000254	0.000784	CcSEcCtD
Etodolac—Insomnia—Risedronate—osteoporosis	0.000254	0.000783	CcSEcCtD
Etodolac—Anxiety—Zoledronate—osteoporosis	0.000253	0.000782	CcSEcCtD
Etodolac—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000253	0.00078	CcSEcCtD
Etodolac—Paraesthesia—Risedronate—osteoporosis	0.000252	0.000778	CcSEcCtD
Etodolac—Pruritus—Estropipate—osteoporosis	0.000251	0.000775	CcSEcCtD
Etodolac—Discomfort—Zoledronate—osteoporosis	0.000251	0.000775	CcSEcCtD
Etodolac—Asthenia—Alendronate—osteoporosis	0.000251	0.000775	CcSEcCtD
Etodolac—Hypersensitivity—Ibandronate—osteoporosis	0.000251	0.000774	CcSEcCtD
Etodolac—Dyspnoea—Risedronate—osteoporosis	0.00025	0.000772	CcSEcCtD
Etodolac—Erythema multiforme—Estradiol—osteoporosis	0.00025	0.000771	CcSEcCtD
Etodolac—Hypotension—Pamidronate—osteoporosis	0.000249	0.000769	CcSEcCtD
Etodolac—Convulsion—Conjugated Estrogens—osteoporosis	0.000249	0.000769	CcSEcCtD
Etodolac—Dry mouth—Zoledronate—osteoporosis	0.000249	0.000767	CcSEcCtD
Etodolac—Fatigue—Ethinyl Estradiol—osteoporosis	0.000248	0.000766	CcSEcCtD
Etodolac—Pruritus—Alendronate—osteoporosis	0.000247	0.000764	CcSEcCtD
Etodolac—Dyspepsia—Risedronate—osteoporosis	0.000247	0.000762	CcSEcCtD
Etodolac—Tinnitus—Estradiol—osteoporosis	0.000246	0.000761	CcSEcCtD
Etodolac—Constipation—Ethinyl Estradiol—osteoporosis	0.000246	0.00076	CcSEcCtD
Etodolac—Confusional state—Zoledronate—osteoporosis	0.000246	0.000758	CcSEcCtD
Etodolac—Hypersensitivity—Calcitriol—osteoporosis	0.000246	0.000758	CcSEcCtD
Etodolac—Flushing—Estradiol—osteoporosis	0.000245	0.000757	CcSEcCtD
Etodolac—Arthralgia—Conjugated Estrogens—osteoporosis	0.000245	0.000755	CcSEcCtD
Etodolac—Myalgia—Conjugated Estrogens—osteoporosis	0.000245	0.000755	CcSEcCtD
Etodolac—Asthenia—Ibandronate—osteoporosis	0.000244	0.000754	CcSEcCtD
Etodolac—Anxiety—Conjugated Estrogens—osteoporosis	0.000244	0.000753	CcSEcCtD
Etodolac—Nausea—Etidronic acid—osteoporosis	0.000244	0.000753	CcSEcCtD
Etodolac—Anaphylactic shock—Zoledronate—osteoporosis	0.000244	0.000752	CcSEcCtD
Etodolac—Oedema—Zoledronate—osteoporosis	0.000244	0.000752	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000243	0.00075	CcSEcCtD
Etodolac—Diarrhoea—Estropipate—osteoporosis	0.000243	0.00075	CcSEcCtD
Etodolac—Infection—Zoledronate—osteoporosis	0.000242	0.000747	CcSEcCtD
Etodolac—Fatigue—Risedronate—osteoporosis	0.000242	0.000747	CcSEcCtD
Etodolac—Insomnia—Pamidronate—osteoporosis	0.000241	0.000745	CcSEcCtD
Etodolac—Pruritus—Ibandronate—osteoporosis	0.000241	0.000744	CcSEcCtD
Etodolac—Pain—Risedronate—osteoporosis	0.00024	0.000741	CcSEcCtD
Etodolac—Constipation—Risedronate—osteoporosis	0.00024	0.000741	CcSEcCtD
Etodolac—Shock—Zoledronate—osteoporosis	0.00024	0.00074	CcSEcCtD
Etodolac—Paraesthesia—Pamidronate—osteoporosis	0.00024	0.000739	CcSEcCtD
Etodolac—Diarrhoea—Alendronate—osteoporosis	0.000239	0.000739	CcSEcCtD
Etodolac—Asthenia—Calcitriol—osteoporosis	0.000239	0.000738	CcSEcCtD
Etodolac—Thrombocytopenia—Zoledronate—osteoporosis	0.000239	0.000736	CcSEcCtD
Etodolac—Dyspnoea—Pamidronate—osteoporosis	0.000238	0.000734	CcSEcCtD
Etodolac—Tachycardia—Zoledronate—osteoporosis	0.000238	0.000734	CcSEcCtD
Etodolac—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000237	0.000732	CcSEcCtD
Etodolac—Chills—Estradiol—osteoporosis	0.000237	0.000732	CcSEcCtD
Etodolac—Somnolence—Pamidronate—osteoporosis	0.000237	0.000732	CcSEcCtD
Etodolac—Pruritus—Calcitriol—osteoporosis	0.000236	0.000728	CcSEcCtD
Etodolac—Hyperhidrosis—Zoledronate—osteoporosis	0.000236	0.000727	CcSEcCtD
Etodolac—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000235	0.000726	CcSEcCtD
Etodolac—Diarrhoea—Raloxifene—osteoporosis	0.000235	0.000726	CcSEcCtD
Etodolac—Dyspepsia—Pamidronate—osteoporosis	0.000235	0.000725	CcSEcCtD
Etodolac—Dizziness—Estropipate—osteoporosis	0.000235	0.000725	CcSEcCtD
Etodolac—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000235	0.000724	CcSEcCtD
Etodolac—Oedema—Conjugated Estrogens—osteoporosis	0.000235	0.000724	CcSEcCtD
Etodolac—Alopecia—Estradiol—osteoporosis	0.000234	0.000721	CcSEcCtD
Etodolac—Infection—Conjugated Estrogens—osteoporosis	0.000233	0.000719	CcSEcCtD
Etodolac—Diarrhoea—Ibandronate—osteoporosis	0.000233	0.000719	CcSEcCtD
Etodolac—Anorexia—Zoledronate—osteoporosis	0.000232	0.000717	CcSEcCtD
Etodolac—Decreased appetite—Pamidronate—osteoporosis	0.000232	0.000716	CcSEcCtD
Etodolac—Dizziness—Alendronate—osteoporosis	0.000231	0.000714	CcSEcCtD
Etodolac—Shock—Conjugated Estrogens—osteoporosis	0.000231	0.000713	CcSEcCtD
Etodolac—Fatigue—Pamidronate—osteoporosis	0.00023	0.00071	CcSEcCtD
Etodolac—Gastrointestinal pain—Risedronate—osteoporosis	0.000229	0.000708	CcSEcCtD
Etodolac—Tachycardia—Conjugated Estrogens—osteoporosis	0.000229	0.000707	CcSEcCtD
Etodolac—Urticaria—Ethinyl Estradiol—osteoporosis	0.000229	0.000706	CcSEcCtD
Etodolac—Pain—Pamidronate—osteoporosis	0.000228	0.000704	CcSEcCtD
Etodolac—Constipation—Pamidronate—osteoporosis	0.000228	0.000704	CcSEcCtD
Etodolac—Diarrhoea—Calcitriol—osteoporosis	0.000228	0.000704	CcSEcCtD
Etodolac—Hypotension—Zoledronate—osteoporosis	0.000228	0.000703	CcSEcCtD
Etodolac—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000228	0.000702	CcSEcCtD
Etodolac—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000228	0.000702	CcSEcCtD
Etodolac—Dizziness—Raloxifene—osteoporosis	0.000227	0.000702	CcSEcCtD
Etodolac—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000227	0.0007	CcSEcCtD
Etodolac—Flatulence—Estradiol—osteoporosis	0.000227	0.0007	CcSEcCtD
Etodolac—Tension—Estradiol—osteoporosis	0.000226	0.000697	CcSEcCtD
Etodolac—Vomiting—Estropipate—osteoporosis	0.000226	0.000697	CcSEcCtD
Etodolac—Dysgeusia—Estradiol—osteoporosis	0.000225	0.000695	CcSEcCtD
Etodolac—Dizziness—Ibandronate—osteoporosis	0.000225	0.000695	CcSEcCtD
Etodolac—Rash—Estropipate—osteoporosis	0.000224	0.000691	CcSEcCtD
Etodolac—Dermatitis—Estropipate—osteoporosis	0.000224	0.00069	CcSEcCtD
Etodolac—Anorexia—Conjugated Estrogens—osteoporosis	0.000224	0.00069	CcSEcCtD
Etodolac—Nervousness—Estradiol—osteoporosis	0.000223	0.00069	CcSEcCtD
Etodolac—Urticaria—Risedronate—osteoporosis	0.000223	0.000688	CcSEcCtD
Etodolac—Headache—Estropipate—osteoporosis	0.000222	0.000687	CcSEcCtD
Etodolac—Vomiting—Alendronate—osteoporosis	0.000222	0.000686	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000222	0.000685	CcSEcCtD
Etodolac—Body temperature increased—Risedronate—osteoporosis	0.000222	0.000685	CcSEcCtD
Etodolac—Abdominal pain—Risedronate—osteoporosis	0.000222	0.000685	CcSEcCtD
Etodolac—Rash—Alendronate—osteoporosis	0.000221	0.000681	CcSEcCtD
Etodolac—Insomnia—Zoledronate—osteoporosis	0.00022	0.00068	CcSEcCtD
Etodolac—Dermatitis—Alendronate—osteoporosis	0.00022	0.00068	CcSEcCtD
Etodolac—Feeling abnormal—Pamidronate—osteoporosis	0.00022	0.000679	CcSEcCtD
Etodolac—Hypotension—Conjugated Estrogens—osteoporosis	0.000219	0.000677	CcSEcCtD
Etodolac—Headache—Alendronate—osteoporosis	0.000219	0.000676	CcSEcCtD
Etodolac—Paraesthesia—Zoledronate—osteoporosis	0.000219	0.000675	CcSEcCtD
Etodolac—Vomiting—Raloxifene—osteoporosis	0.000219	0.000675	CcSEcCtD
Etodolac—Gastrointestinal pain—Pamidronate—osteoporosis	0.000218	0.000673	CcSEcCtD
Etodolac—Dyspnoea—Zoledronate—osteoporosis	0.000217	0.000671	CcSEcCtD
Etodolac—Rash—Raloxifene—osteoporosis	0.000217	0.000669	CcSEcCtD
Etodolac—Dermatitis—Raloxifene—osteoporosis	0.000217	0.000669	CcSEcCtD
Etodolac—Somnolence—Zoledronate—osteoporosis	0.000217	0.000669	CcSEcCtD
Etodolac—Vomiting—Ibandronate—osteoporosis	0.000216	0.000668	CcSEcCtD
Etodolac—Tremor—Estradiol—osteoporosis	0.000216	0.000665	CcSEcCtD
Etodolac—Headache—Raloxifene—osteoporosis	0.000215	0.000665	CcSEcCtD
Etodolac—Rash—Ibandronate—osteoporosis	0.000215	0.000663	CcSEcCtD
Etodolac—Dermatitis—Ibandronate—osteoporosis	0.000214	0.000662	CcSEcCtD
Etodolac—Dyspepsia—Zoledronate—osteoporosis	0.000214	0.000662	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000214	0.00066	CcSEcCtD
Etodolac—Ill-defined disorder—Estradiol—osteoporosis	0.000213	0.000659	CcSEcCtD
Etodolac—Headache—Ibandronate—osteoporosis	0.000213	0.000658	CcSEcCtD
Etodolac—Insomnia—Conjugated Estrogens—osteoporosis	0.000212	0.000655	CcSEcCtD
Etodolac—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000212	0.000655	CcSEcCtD
Etodolac—Vomiting—Calcitriol—osteoporosis	0.000212	0.000654	CcSEcCtD
Etodolac—Decreased appetite—Zoledronate—osteoporosis	0.000212	0.000654	CcSEcCtD
Etodolac—Nausea—Estropipate—osteoporosis	0.000211	0.000651	CcSEcCtD
Etodolac—Abdominal pain—Pamidronate—osteoporosis	0.000211	0.000651	CcSEcCtD
Etodolac—Body temperature increased—Pamidronate—osteoporosis	0.000211	0.000651	CcSEcCtD
Etodolac—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000211	0.00065	CcSEcCtD
Etodolac—Angioedema—Estradiol—osteoporosis	0.00021	0.000649	CcSEcCtD
Etodolac—Rash—Calcitriol—osteoporosis	0.00021	0.000649	CcSEcCtD
Etodolac—Fatigue—Zoledronate—osteoporosis	0.00021	0.000648	CcSEcCtD
Etodolac—Dermatitis—Calcitriol—osteoporosis	0.00021	0.000648	CcSEcCtD
Etodolac—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000209	0.000646	CcSEcCtD
Etodolac—Headache—Calcitriol—osteoporosis	0.000209	0.000645	CcSEcCtD
Etodolac—Somnolence—Conjugated Estrogens—osteoporosis	0.000209	0.000644	CcSEcCtD
Etodolac—Pain—Zoledronate—osteoporosis	0.000208	0.000643	CcSEcCtD
Etodolac—Constipation—Zoledronate—osteoporosis	0.000208	0.000643	CcSEcCtD
Etodolac—Nausea—Alendronate—osteoporosis	0.000208	0.000641	CcSEcCtD
Etodolac—Malaise—Estradiol—osteoporosis	0.000207	0.00064	CcSEcCtD
Etodolac—Hypersensitivity—Risedronate—osteoporosis	0.000207	0.000638	CcSEcCtD
Etodolac—Vertigo—Estradiol—osteoporosis	0.000207	0.000638	CcSEcCtD
Etodolac—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000207	0.000638	CcSEcCtD
Etodolac—Asthenia—Ethinyl Estradiol—osteoporosis	0.000206	0.000637	CcSEcCtD
Etodolac—Syncope—Estradiol—osteoporosis	0.000206	0.000637	CcSEcCtD
Etodolac—Nausea—Raloxifene—osteoporosis	0.000204	0.000631	CcSEcCtD
Etodolac—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000204	0.00063	CcSEcCtD
Etodolac—Pruritus—Ethinyl Estradiol—osteoporosis	0.000204	0.000629	CcSEcCtD
Etodolac—Palpitations—Estradiol—osteoporosis	0.000203	0.000628	CcSEcCtD
Etodolac—Fatigue—Conjugated Estrogens—osteoporosis	0.000202	0.000624	CcSEcCtD
Etodolac—Nausea—Ibandronate—osteoporosis	0.000202	0.000624	CcSEcCtD
Etodolac—Loss of consciousness—Estradiol—osteoporosis	0.000202	0.000624	CcSEcCtD
Etodolac—Asthenia—Risedronate—osteoporosis	0.000201	0.000621	CcSEcCtD
Etodolac—Feeling abnormal—Zoledronate—osteoporosis	0.000201	0.00062	CcSEcCtD
Etodolac—Pain—Conjugated Estrogens—osteoporosis	0.000201	0.000619	CcSEcCtD
Etodolac—Constipation—Conjugated Estrogens—osteoporosis	0.000201	0.000619	CcSEcCtD
Etodolac—Gastrointestinal pain—Zoledronate—osteoporosis	0.000199	0.000615	CcSEcCtD
Etodolac—Hypertension—Estradiol—osteoporosis	0.000199	0.000613	CcSEcCtD
Etodolac—Pruritus—Risedronate—osteoporosis	0.000199	0.000613	CcSEcCtD
Etodolac—Nausea—Calcitriol—osteoporosis	0.000198	0.000611	CcSEcCtD
Etodolac—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000197	0.000608	CcSEcCtD
Etodolac—Hypersensitivity—Pamidronate—osteoporosis	0.000197	0.000607	CcSEcCtD
Etodolac—Myalgia—Estradiol—osteoporosis	0.000196	0.000605	CcSEcCtD
Etodolac—Arthralgia—Estradiol—osteoporosis	0.000196	0.000605	CcSEcCtD
Etodolac—Anxiety—Estradiol—osteoporosis	0.000195	0.000603	CcSEcCtD
Etodolac—Urticaria—Zoledronate—osteoporosis	0.000194	0.000598	CcSEcCtD
Etodolac—Discomfort—Estradiol—osteoporosis	0.000194	0.000597	CcSEcCtD
Etodolac—Abdominal pain—Zoledronate—osteoporosis	0.000193	0.000595	CcSEcCtD
Etodolac—Body temperature increased—Zoledronate—osteoporosis	0.000193	0.000595	CcSEcCtD
Etodolac—Diarrhoea—Risedronate—osteoporosis	0.000192	0.000593	CcSEcCtD
Etodolac—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000192	0.000592	CcSEcCtD
Etodolac—Dry mouth—Estradiol—osteoporosis	0.000192	0.000591	CcSEcCtD
Etodolac—Asthenia—Pamidronate—osteoporosis	0.000191	0.000591	CcSEcCtD
Etodolac—Dizziness—Ethinyl Estradiol—osteoporosis	0.00019	0.000587	CcSEcCtD
Etodolac—Confusional state—Estradiol—osteoporosis	0.000189	0.000584	CcSEcCtD
Etodolac—Pruritus—Pamidronate—osteoporosis	0.000189	0.000583	CcSEcCtD
Etodolac—Anaphylactic shock—Estradiol—osteoporosis	0.000188	0.00058	CcSEcCtD
Etodolac—Oedema—Estradiol—osteoporosis	0.000188	0.00058	CcSEcCtD
Etodolac—Infection—Estradiol—osteoporosis	0.000187	0.000576	CcSEcCtD
Etodolac—Urticaria—Conjugated Estrogens—osteoporosis	0.000186	0.000575	CcSEcCtD
Etodolac—Dizziness—Risedronate—osteoporosis	0.000186	0.000573	CcSEcCtD
Etodolac—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000185	0.000573	CcSEcCtD
Etodolac—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000185	0.000573	CcSEcCtD
Etodolac—Shock—Estradiol—osteoporosis	0.000185	0.00057	CcSEcCtD
Etodolac—Tachycardia—Estradiol—osteoporosis	0.000183	0.000566	CcSEcCtD
Etodolac—Vomiting—Ethinyl Estradiol—osteoporosis	0.000183	0.000565	CcSEcCtD
Etodolac—Diarrhoea—Pamidronate—osteoporosis	0.000183	0.000563	CcSEcCtD
Etodolac—Hyperhidrosis—Estradiol—osteoporosis	0.000182	0.00056	CcSEcCtD
Etodolac—Rash—Ethinyl Estradiol—osteoporosis	0.000181	0.00056	CcSEcCtD
Etodolac—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000181	0.00056	CcSEcCtD
Etodolac—Headache—Ethinyl Estradiol—osteoporosis	0.00018	0.000557	CcSEcCtD
Etodolac—Hypersensitivity—Zoledronate—osteoporosis	0.00018	0.000554	CcSEcCtD
Etodolac—Vomiting—Risedronate—osteoporosis	0.000178	0.000551	CcSEcCtD
Etodolac—Rash—Risedronate—osteoporosis	0.000177	0.000546	CcSEcCtD
Etodolac—Dermatitis—Risedronate—osteoporosis	0.000177	0.000546	CcSEcCtD
Etodolac—Dizziness—Pamidronate—osteoporosis	0.000176	0.000545	CcSEcCtD
Etodolac—Headache—Risedronate—osteoporosis	0.000176	0.000543	CcSEcCtD
Etodolac—Asthenia—Zoledronate—osteoporosis	0.000175	0.00054	CcSEcCtD
Etodolac—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000173	0.000534	CcSEcCtD
Etodolac—Pruritus—Zoledronate—osteoporosis	0.000172	0.000532	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000171	0.000528	CcSEcCtD
Etodolac—Nausea—Ethinyl Estradiol—osteoporosis	0.000171	0.000528	CcSEcCtD
Etodolac—Insomnia—Estradiol—osteoporosis	0.00017	0.000524	CcSEcCtD
Etodolac—Vomiting—Pamidronate—osteoporosis	0.00017	0.000524	CcSEcCtD
Etodolac—Paraesthesia—Estradiol—osteoporosis	0.000169	0.00052	CcSEcCtD
Etodolac—Asthenia—Conjugated Estrogens—osteoporosis	0.000168	0.00052	CcSEcCtD
Etodolac—Rash—Pamidronate—osteoporosis	0.000168	0.000519	CcSEcCtD
Etodolac—Dermatitis—Pamidronate—osteoporosis	0.000168	0.000519	CcSEcCtD
Etodolac—Dyspnoea—Estradiol—osteoporosis	0.000167	0.000517	CcSEcCtD
Etodolac—Headache—Pamidronate—osteoporosis	0.000167	0.000516	CcSEcCtD
Etodolac—Somnolence—Estradiol—osteoporosis	0.000167	0.000515	CcSEcCtD
Etodolac—Diarrhoea—Zoledronate—osteoporosis	0.000167	0.000515	CcSEcCtD
Etodolac—Nausea—Risedronate—osteoporosis	0.000167	0.000515	CcSEcCtD
Etodolac—Pruritus—Conjugated Estrogens—osteoporosis	0.000166	0.000512	CcSEcCtD
Etodolac—Dyspepsia—Estradiol—osteoporosis	0.000165	0.00051	CcSEcCtD
Etodolac—Decreased appetite—Estradiol—osteoporosis	0.000163	0.000504	CcSEcCtD
Etodolac—Fatigue—Estradiol—osteoporosis	0.000162	0.0005	CcSEcCtD
Etodolac—Dizziness—Zoledronate—osteoporosis	0.000161	0.000497	CcSEcCtD
Etodolac—Pain—Estradiol—osteoporosis	0.000161	0.000496	CcSEcCtD
Etodolac—Constipation—Estradiol—osteoporosis	0.000161	0.000496	CcSEcCtD
Etodolac—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000161	0.000496	CcSEcCtD
Etodolac—Nausea—Pamidronate—osteoporosis	0.000158	0.000489	CcSEcCtD
Etodolac—Dizziness—Conjugated Estrogens—osteoporosis	0.000155	0.000479	CcSEcCtD
Etodolac—Vomiting—Zoledronate—osteoporosis	0.000155	0.000478	CcSEcCtD
Etodolac—Feeling abnormal—Estradiol—osteoporosis	0.000155	0.000478	CcSEcCtD
Etodolac—Rash—Zoledronate—osteoporosis	0.000154	0.000474	CcSEcCtD
Etodolac—Gastrointestinal pain—Estradiol—osteoporosis	0.000154	0.000474	CcSEcCtD
Etodolac—Dermatitis—Zoledronate—osteoporosis	0.000153	0.000474	CcSEcCtD
Etodolac—Headache—Zoledronate—osteoporosis	0.000153	0.000471	CcSEcCtD
Etodolac—Vomiting—Conjugated Estrogens—osteoporosis	0.000149	0.00046	CcSEcCtD
Etodolac—Urticaria—Estradiol—osteoporosis	0.000149	0.00046	CcSEcCtD
Etodolac—Abdominal pain—Estradiol—osteoporosis	0.000148	0.000458	CcSEcCtD
Etodolac—Body temperature increased—Estradiol—osteoporosis	0.000148	0.000458	CcSEcCtD
Etodolac—Rash—Conjugated Estrogens—osteoporosis	0.000148	0.000457	CcSEcCtD
Etodolac—Dermatitis—Conjugated Estrogens—osteoporosis	0.000148	0.000456	CcSEcCtD
Etodolac—Headache—Conjugated Estrogens—osteoporosis	0.000147	0.000454	CcSEcCtD
Etodolac—Nausea—Zoledronate—osteoporosis	0.000145	0.000447	CcSEcCtD
Etodolac—Nausea—Conjugated Estrogens—osteoporosis	0.000139	0.00043	CcSEcCtD
Etodolac—Hypersensitivity—Estradiol—osteoporosis	0.000138	0.000427	CcSEcCtD
Etodolac—Asthenia—Estradiol—osteoporosis	0.000135	0.000416	CcSEcCtD
Etodolac—Pruritus—Estradiol—osteoporosis	0.000133	0.00041	CcSEcCtD
Etodolac—Diarrhoea—Estradiol—osteoporosis	0.000128	0.000397	CcSEcCtD
Etodolac—Dizziness—Estradiol—osteoporosis	0.000124	0.000383	CcSEcCtD
Etodolac—Vomiting—Estradiol—osteoporosis	0.000119	0.000369	CcSEcCtD
Etodolac—Rash—Estradiol—osteoporosis	0.000118	0.000365	CcSEcCtD
Etodolac—Dermatitis—Estradiol—osteoporosis	0.000118	0.000365	CcSEcCtD
Etodolac—Headache—Estradiol—osteoporosis	0.000118	0.000363	CcSEcCtD
Etodolac—Nausea—Estradiol—osteoporosis	0.000112	0.000344	CcSEcCtD
Etodolac—ALB—Hemostasis—VCL—osteoporosis	7.61e-05	0.000713	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MGLL—osteoporosis	7.57e-05	0.00071	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.48e-05	0.000702	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.48e-05	0.000701	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ATIC—osteoporosis	7.45e-05	0.000699	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PNP—osteoporosis	7.45e-05	0.000699	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—P4HB—osteoporosis	7.45e-05	0.000699	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP27A1—osteoporosis	7.45e-05	0.000699	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	7.42e-05	0.000696	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	7.42e-05	0.000696	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	7.39e-05	0.000693	CbGpPWpGaD
Etodolac—RXRA—Metabolism—IDH2—osteoporosis	7.39e-05	0.000693	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—TGFB1—osteoporosis	7.35e-05	0.000689	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GAPDH—osteoporosis	7.31e-05	0.000686	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.29e-05	0.000683	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	7.26e-05	0.00068	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ACP5—osteoporosis	7.25e-05	0.00068	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.14e-05	0.00067	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—RAP1A—osteoporosis	7.12e-05	0.000668	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.12e-05	0.000668	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IL6—osteoporosis	6.97e-05	0.000654	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP27A1—osteoporosis	6.95e-05	0.000652	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—FDPS—osteoporosis	6.82e-05	0.00064	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PKM—osteoporosis	6.82e-05	0.00064	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.82e-05	0.00064	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.8e-05	0.000638	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TNF—osteoporosis	6.78e-05	0.000636	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	6.77e-05	0.000635	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ACP5—osteoporosis	6.76e-05	0.000634	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TPI1—osteoporosis	6.74e-05	0.000632	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	6.73e-05	0.000631	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.68e-05	0.000626	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	6.66e-05	0.000624	CbGpPWpGaD
Etodolac—PTGS2—Disease—GSN—osteoporosis	6.57e-05	0.000616	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—ESR1—osteoporosis	6.51e-05	0.000611	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PGLS—osteoporosis	6.47e-05	0.000606	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPD2—osteoporosis	6.47e-05	0.000606	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—IDH2—osteoporosis	6.44e-05	0.000604	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—LEP—osteoporosis	6.42e-05	0.000602	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	6.4e-05	0.0006	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.37e-05	0.000597	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAP1A—osteoporosis	6.36e-05	0.000596	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.35e-05	0.000596	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CA2—osteoporosis	6.34e-05	0.000594	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—OXCT1—osteoporosis	6.34e-05	0.000594	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—P4HB—osteoporosis	6.34e-05	0.000594	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TPI1—osteoporosis	6.29e-05	0.000589	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—TGFB1—osteoporosis	6.23e-05	0.000584	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GAPDH—osteoporosis	6.22e-05	0.000583	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MGLL—osteoporosis	6.17e-05	0.000579	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—RAP1A—osteoporosis	6.06e-05	0.000568	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP27A1—osteoporosis	6.05e-05	0.000568	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.05e-05	0.000568	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	5.93e-05	0.000556	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PNP—osteoporosis	5.92e-05	0.000555	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ATIC—osteoporosis	5.92e-05	0.000555	CbGpPWpGaD
Etodolac—RXRA—Metabolism—P4HB—osteoporosis	5.91e-05	0.000554	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ACP5—osteoporosis	5.89e-05	0.000552	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.83e-05	0.000546	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.82e-05	0.000546	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.82e-05	0.000545	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GAPDH—osteoporosis	5.8e-05	0.000544	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PSMA2—osteoporosis	5.79e-05	0.000543	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PSMA5—osteoporosis	5.79e-05	0.000543	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FGA—osteoporosis	5.76e-05	0.000541	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ENO1—osteoporosis	5.76e-05	0.00054	CbGpPWpGaD
Etodolac—PTGS2—Disease—LRP5—osteoporosis	5.71e-05	0.000536	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PSMA2—osteoporosis	5.67e-05	0.000532	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PSMA5—osteoporosis	5.67e-05	0.000532	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MYC—osteoporosis	5.65e-05	0.00053	CbGpPWpGaD
Etodolac—RXRA—Metabolism—RAP1A—osteoporosis	5.65e-05	0.00053	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	5.64e-05	0.000529	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.59e-05	0.000524	CbGpPWpGaD
Etodolac—ALB—Metabolism—PKM—osteoporosis	5.52e-05	0.000518	CbGpPWpGaD
Etodolac—ALB—Metabolism—FDPS—osteoporosis	5.52e-05	0.000518	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TPI1—osteoporosis	5.48e-05	0.000513	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—osteoporosis	5.47e-05	0.000513	CbGpPWpGaD
Etodolac—PTGS2—Disease—LRP6—osteoporosis	5.46e-05	0.000512	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—TNF—osteoporosis	5.39e-05	0.000505	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6R—osteoporosis	5.38e-05	0.000505	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	5.37e-05	0.000504	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TNF—osteoporosis	5.27e-05	0.000494	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—IDH2—osteoporosis	5.25e-05	0.000492	CbGpPWpGaD
Etodolac—PTGS2—Disease—RPL24—osteoporosis	5.25e-05	0.000492	CbGpPWpGaD
Etodolac—PTGS2—Disease—LTF—osteoporosis	5.25e-05	0.000492	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FGB—osteoporosis	5.24e-05	0.000492	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPD2—osteoporosis	5.23e-05	0.000491	CbGpPWpGaD
Etodolac—ALB—Metabolism—PGLS—osteoporosis	5.23e-05	0.000491	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ESR2—osteoporosis	5.17e-05	0.000485	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—P4HB—osteoporosis	5.15e-05	0.000483	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GAPDH—osteoporosis	5.05e-05	0.000474	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CA2—osteoporosis	5.03e-05	0.000472	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—OXCT1—osteoporosis	5.03e-05	0.000472	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.95e-05	0.000465	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP27A1—osteoporosis	4.94e-05	0.000463	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.93e-05	0.000462	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—RAP1A—osteoporosis	4.92e-05	0.000462	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MGLL—osteoporosis	4.9e-05	0.00046	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ENO1—osteoporosis	4.9e-05	0.000459	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PSMA2—osteoporosis	4.82e-05	0.000452	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PSMA5—osteoporosis	4.82e-05	0.000452	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ACP5—osteoporosis	4.8e-05	0.00045	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—POMC—osteoporosis	4.79e-05	0.000449	CbGpPWpGaD
Etodolac—ALB—Metabolism—ATIC—osteoporosis	4.79e-05	0.000449	CbGpPWpGaD
Etodolac—ALB—Metabolism—PNP—osteoporosis	4.79e-05	0.000449	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.74e-05	0.000445	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.62e-05	0.000433	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.61e-05	0.000432	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP19A1—osteoporosis	4.6e-05	0.000432	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ENO1—osteoporosis	4.57e-05	0.000428	CbGpPWpGaD
Etodolac—PTGS2—Disease—ACP5—osteoporosis	4.55e-05	0.000427	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FDPS—osteoporosis	4.52e-05	0.000424	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PKM—osteoporosis	4.52e-05	0.000424	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PSMA2—osteoporosis	4.5e-05	0.000422	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PSMA5—osteoporosis	4.5e-05	0.000422	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TPI1—osteoporosis	4.46e-05	0.000419	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—osteoporosis	4.35e-05	0.000408	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.29e-05	0.000402	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PGLS—osteoporosis	4.28e-05	0.000402	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPD2—osteoporosis	4.28e-05	0.000402	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—osteoporosis	4.25e-05	0.000398	CbGpPWpGaD
Etodolac—PTGS2—Disease—TPI1—osteoporosis	4.23e-05	0.000397	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—P4HB—osteoporosis	4.2e-05	0.000394	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—IDH2—osteoporosis	4.17e-05	0.000391	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GAPDH—osteoporosis	4.12e-05	0.000386	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—VDR—osteoporosis	4.1e-05	0.000385	CbGpPWpGaD
Etodolac—ALB—Metabolism—OXCT1—osteoporosis	4.07e-05	0.000382	CbGpPWpGaD
Etodolac—ALB—Metabolism—CA2—osteoporosis	4.07e-05	0.000382	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—RAP1A—osteoporosis	4.01e-05	0.000376	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ENO1—osteoporosis	3.98e-05	0.000373	CbGpPWpGaD
Etodolac—PTGS2—Disease—P4HB—osteoporosis	3.98e-05	0.000373	CbGpPWpGaD
Etodolac—ALB—Metabolism—MGLL—osteoporosis	3.97e-05	0.000372	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PSMA2—osteoporosis	3.92e-05	0.000368	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PSMA5—osteoporosis	3.92e-05	0.000368	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP27A1—osteoporosis	3.92e-05	0.000367	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PNP—osteoporosis	3.92e-05	0.000367	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ATIC—osteoporosis	3.92e-05	0.000367	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP19A1—osteoporosis	3.91e-05	0.000367	CbGpPWpGaD
Etodolac—PTGS2—Disease—GAPDH—osteoporosis	3.9e-05	0.000366	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.85e-05	0.000361	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.84e-05	0.00036	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ACP5—osteoporosis	3.81e-05	0.000357	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.76e-05	0.000353	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ADCY5—osteoporosis	3.76e-05	0.000353	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GPX1—osteoporosis	3.75e-05	0.000351	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.74e-05	0.000351	CbGpPWpGaD
Etodolac—PTGS2—Disease—NFATC1—osteoporosis	3.71e-05	0.000348	CbGpPWpGaD
Etodolac—PTGS2—Disease—DKK1—osteoporosis	3.68e-05	0.000345	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP19A1—osteoporosis	3.65e-05	0.000342	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.58e-05	0.000336	CbGpPWpGaD
Etodolac—PTGS2—Disease—WNT1—osteoporosis	3.55e-05	0.000333	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TPI1—osteoporosis	3.54e-05	0.000332	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.5e-05	0.000328	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—MTHFR—osteoporosis	3.46e-05	0.000324	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGA—osteoporosis	3.45e-05	0.000323	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—osteoporosis	3.39e-05	0.000318	CbGpPWpGaD
Etodolac—ALB—Metabolism—IDH2—osteoporosis	3.37e-05	0.000316	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—P4HB—osteoporosis	3.33e-05	0.000312	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—OXCT1—osteoporosis	3.33e-05	0.000312	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CA2—osteoporosis	3.33e-05	0.000312	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GAPDH—osteoporosis	3.27e-05	0.000307	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MGLL—osteoporosis	3.25e-05	0.000304	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ENO1—osteoporosis	3.24e-05	0.000304	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ADCY5—osteoporosis	3.2e-05	0.0003	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PSMA5—osteoporosis	3.2e-05	0.0003	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PSMA2—osteoporosis	3.2e-05	0.0003	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GPX1—osteoporosis	3.19e-05	0.000299	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RAP1A—osteoporosis	3.19e-05	0.000299	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TGFB1—osteoporosis	3.18e-05	0.000298	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP19A1—osteoporosis	3.18e-05	0.000298	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP27A1—osteoporosis	3.17e-05	0.000297	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ESR1—osteoporosis	3.14e-05	0.000294	CbGpPWpGaD
Etodolac—ALB—Metabolism—ACP5—osteoporosis	3.08e-05	0.000289	CbGpPWpGaD
Etodolac—PTGS2—Disease—ENO1—osteoporosis	3.07e-05	0.000288	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.06e-05	0.000287	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.04e-05	0.000286	CbGpPWpGaD
Etodolac—PTGS2—Disease—PSMA2—osteoporosis	3.03e-05	0.000284	CbGpPWpGaD
Etodolac—PTGS2—Disease—PSMA5—osteoporosis	3.03e-05	0.000284	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ADCY5—osteoporosis	2.98e-05	0.00028	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GPX1—osteoporosis	2.97e-05	0.000279	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—osteoporosis	2.97e-05	0.000279	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MTHFR—osteoporosis	2.94e-05	0.000276	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.91e-05	0.000272	CbGpPWpGaD
Etodolac—ALB—Metabolism—TPI1—osteoporosis	2.87e-05	0.000269	CbGpPWpGaD
Etodolac—PTGS2—Disease—CALCA—osteoporosis	2.82e-05	0.000265	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.78e-05	0.00026	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—POMC—osteoporosis	2.77e-05	0.000259	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.76e-05	0.000259	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—IDH2—osteoporosis	2.76e-05	0.000259	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MTHFR—osteoporosis	2.74e-05	0.000257	CbGpPWpGaD
Etodolac—ALB—Metabolism—P4HB—osteoporosis	2.7e-05	0.000253	CbGpPWpGaD
Etodolac—ALB—Metabolism—GAPDH—osteoporosis	2.65e-05	0.000248	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ADCY5—osteoporosis	2.6e-05	0.000244	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.59e-05	0.000243	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP19A1—osteoporosis	2.59e-05	0.000243	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GPX1—osteoporosis	2.59e-05	0.000243	CbGpPWpGaD
Etodolac—ALB—Metabolism—RAP1A—osteoporosis	2.58e-05	0.000242	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ENO1—osteoporosis	2.57e-05	0.000241	CbGpPWpGaD
Etodolac—PTGS2—Disease—KL—osteoporosis	2.56e-05	0.00024	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PSMA2—osteoporosis	2.54e-05	0.000238	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PSMA5—osteoporosis	2.54e-05	0.000238	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ACP5—osteoporosis	2.52e-05	0.000237	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.49e-05	0.000234	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—osteoporosis	2.4e-05	0.000225	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MTHFR—osteoporosis	2.39e-05	0.000224	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF1—osteoporosis	2.37e-05	0.000223	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—POMC—osteoporosis	2.35e-05	0.000221	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TPI1—osteoporosis	2.35e-05	0.00022	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.25e-05	0.000211	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—P4HB—osteoporosis	2.21e-05	0.000207	CbGpPWpGaD
Etodolac—RXRA—Metabolism—POMC—osteoporosis	2.19e-05	0.000206	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GAPDH—osteoporosis	2.17e-05	0.000203	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ADCY5—osteoporosis	2.12e-05	0.000199	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GPX1—osteoporosis	2.11e-05	0.000198	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RAP1A—osteoporosis	2.11e-05	0.000198	CbGpPWpGaD
Etodolac—ALB—Metabolism—ENO1—osteoporosis	2.08e-05	0.000195	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP19A1—osteoporosis	2.06e-05	0.000193	CbGpPWpGaD
Etodolac—ALB—Metabolism—PSMA2—osteoporosis	2.05e-05	0.000192	CbGpPWpGaD
Etodolac—ALB—Metabolism—PSMA5—osteoporosis	2.05e-05	0.000192	CbGpPWpGaD
Etodolac—PTGS2—Disease—ADCY5—osteoporosis	2.01e-05	0.000188	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTHFR—osteoporosis	1.95e-05	0.000183	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—POMC—osteoporosis	1.91e-05	0.000179	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTHFR—osteoporosis	1.85e-05	0.000173	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.84e-05	0.000172	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS2—osteoporosis	1.76e-05	0.000165	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ENO1—osteoporosis	1.71e-05	0.00016	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000158	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PSMA5—osteoporosis	1.68e-05	0.000158	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PSMA2—osteoporosis	1.68e-05	0.000158	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPX1—osteoporosis	1.68e-05	0.000157	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP19A1—osteoporosis	1.67e-05	0.000156	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—osteoporosis	1.63e-05	0.000153	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—POMC—osteoporosis	1.56e-05	0.000146	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTHFR—osteoporosis	1.55e-05	0.000145	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS1—osteoporosis	1.53e-05	0.000144	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6R—osteoporosis	1.44e-05	0.000135	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—osteoporosis	1.42e-05	0.000133	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.36e-05	0.000128	CbGpPWpGaD
Etodolac—ALB—Metabolism—ADCY5—osteoporosis	1.36e-05	0.000128	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPX1—osteoporosis	1.36e-05	0.000127	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTHFR—osteoporosis	1.25e-05	0.000117	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—POMC—osteoporosis	1.24e-05	0.000116	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ADCY5—osteoporosis	1.11e-05	0.000104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPX1—osteoporosis	1.11e-05	0.000104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTHFR—osteoporosis	1.02e-05	9.61e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—POMC—osteoporosis	1e-05	9.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—osteoporosis	8.54e-06	8.01e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—osteoporosis	8.52e-06	7.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—POMC—osteoporosis	8.19e-06	7.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—osteoporosis	6.42e-06	6.02e-05	CbGpPWpGaD
